| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Chardonnet Laurent is a Chief Financial Officer at PRLD. Recent filings cover 3 purchases and 0 sales. Those positions are worth an estimated $232K at current prices.
Our model assigns Chardonnet Laurent a below-average insider score of 45/100, based on 3 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -8.6%.
Chardonnet Laurent's largest disclosed position is in PRLD as Chief Financial Officer, worth about $232K. Net of sales, the recent Form 4 record there shows accumulation of 25,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2023 | PRLD Prelude Therapeutics Inc | Chief Financial Officer | Buy | 5,000 | $5.50 | $27,500.00 | +13.5% | -38.7% | -24.4% | |
| Dec 8, 2022 | PRLD Prelude Therapeutics Inc | Chief Financial Officer | Buy | 10,000 | $4.76 | $47,600.00 | +38.7% | +19.2% | -33.6% | |
| Jun 1, 2022 | PRLD Prelude Therapeutics Inc | Chief Financial Officer | Buy | 10,000 | $4.23 | $42,300.00 | +69.0% | +69.1% | +32.1% |